5442102025-01-012025-03-315442102025-03-315442102025-01-012025-03-31CompositionOfBoardOfDirectors15442102025-03-31CompositionOfBoardOfDirectors15442102025-01-012025-03-31CompositionOfBoardOfDirectors25442102025-03-31CompositionOfBoardOfDirectors25442102025-01-012025-03-31CompositionOfBoardOfDirectors35442102025-03-31CompositionOfBoardOfDirectors35442102025-01-012025-03-31CompositionOfBoardOfDirectors45442102025-03-31CompositionOfBoardOfDirectors45442102025-01-012025-03-31CompositionOfBoardOfDirectors55442102025-03-31CompositionOfBoardOfDirectors55442102025-01-012025-03-31CompositionOfBoardOfDirectors65442102025-03-31CompositionOfBoardOfDirectors65442102025-01-012025-03-31CompositionOfBoardOfDirectors75442102025-03-31CompositionOfBoardOfDirectors75442102025-01-012025-03-31CompositionOfBoardOfDirectors85442102025-03-31CompositionOfBoardOfDirectors85442102025-01-012025-03-31CompositionOfBoardOfDirectors95442102025-03-31CompositionOfBoardOfDirectors95442102025-01-012025-03-31CompositionOfBoardOfDirectors105442102025-03-31CompositionOfBoardOfDirectors105442102025-01-012025-03-31CompositionOfCommittees145442102025-03-31CompositionOfCommittees145442102025-01-012025-03-31CompositionOfCommittees155442102025-03-31CompositionOfCommittees155442102025-01-012025-03-31CompositionOfCommittees165442102025-03-31CompositionOfCommittees165442102025-01-012025-03-31CompositionOfCommittees415442102025-03-31CompositionOfCommittees415442102025-01-012025-03-31CompositionOfCommittees425442102025-03-31CompositionOfCommittees425442102025-01-012025-03-31CompositionOfCommittees435442102025-03-31CompositionOfCommittees435442102025-01-012025-03-31CompositionOfCommittees685442102025-03-31CompositionOfCommittees685442102025-01-012025-03-31CompositionOfCommittees695442102025-03-31CompositionOfCommittees695442102025-01-012025-03-31CompositionOfCommittees705442102025-03-31CompositionOfCommittees705442102025-01-012025-03-31CompositionOfCommittees955442102025-03-31CompositionOfCommittees955442102025-01-012025-03-31CompositionOfCommittees965442102025-03-31CompositionOfCommittees965442102025-01-012025-03-31CompositionOfCommittees975442102025-03-31CompositionOfCommittees975442102025-01-012025-03-31CompositionOfCommittees985442102025-03-31CompositionOfCommittees985442102025-01-012025-03-31CompositionOfCommittees1225442102025-03-31CompositionOfCommittees1225442102025-01-012025-03-31CompositionOfCommittees1235442102025-03-31CompositionOfCommittees1235442102025-01-012025-03-31CompositionOfCommittees1245442102025-03-31CompositionOfCommittees1245442102025-03-31MeetingOfBoardOfDirectors15442102025-01-012025-03-31MeetingOfBoardOfDirectors15442102025-03-31MeetingOfBoardOfDirectors25442102025-01-012025-03-31MeetingOfBoardOfDirectors25442102025-01-012025-03-31MeetingOfCommittees15442102025-03-31MeetingOfCommittees15442102025-01-012025-03-31MeetingOfCommittees25442102025-03-31MeetingOfCommittees25442102025-01-012025-03-31MeetingOfCommittees35442102025-03-31MeetingOfCommittees35442102025-01-012025-03-31MeetingOfCommittees45442102025-03-31MeetingOfCommittees45442102025-01-012025-03-31MeetingOfCommittees55442102025-03-31MeetingOfCommittees55442102025-01-012025-03-31MeetingOfCommittees65442102025-03-31MeetingOfCommittees65442102025-01-012025-03-31MeetingOfCommittees75442102025-03-31MeetingOfCommittees75442102025-01-012025-03-31MeetingOfCommittees85442102025-03-31MeetingOfCommittees85442102024-12-315442102025-03-31OngoingTaxLitigationsOrDisputesDomain15442102025-03-31OngoingTaxLitigationsOrDisputesDomain2xbrli:pure544210EMCURENOTLISTEDINE168P01015EMCURE PHARMACEUTICALS LIMITED2024-04-012025-03-31Yearly2025-03-31EquitytruetruefalseNo event has occurred, during the period January 01, 2025 to March 31, 2025, in terms of sub-para 1 of para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.falseNo event has occurred, during the period January 01, 2025 to March 31, 2025, in terms of sub-para 20 of para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as per prescribed thresholdtruefalseNo loan (or other form of debt), guarantee / comfort letter (by whatever name called) or security provided in connection with any loan or any other form of debt has been given directly or indirectly by the Company to any company other than those exluded in reference to notes of the said disclosures, for the period October 01, 2024 to March 31, 2025.trueAny othertrueCOME00369OriginaltruefalseMrBerjis Minoo Desai00153675Non-Executive - Non Independent DirectorChairperson1956-08-02falseActiveNA1997-04-032022-07-287361MrSatish Ramanlal MehtaAAVPM4447J00118691Executive DirectorNot ApplicableCEO-MD1951-01-13falseActiveNA1981-04-162022-04-011010MrSunil Rajanikant Mehta00118469Executive DirectorNot Applicable1963-03-23falseActiveNA2013-06-052023-06-051010MrsNamita Vikas ThaparAEDPM2995R05318899Executive DirectorNot Applicable1977-03-21falseActiveNA2014-07-282024-07-282100MrSamit Satish Mehta00332562Executive DirectorNot Applicable1980-04-04falseActiveNA2022-07-282022-07-281000MrMukund Keshao GurjarACGPG3335A00026843Executive DirectorNot Applicable1952-08-28falseActiveNA2001-07-232022-08-281000MrPalamadai Sundararajan Jayakumar01173236Non-Executive - Independent DirectorNot Applicable1962-04-08falseActiveNA2020-07-222023-07-2256.177104MrVijay Keshav GokhaleAESPG6549Q09134089Non-Executive - Independent DirectorNot Applicable1959-01-24falseActiveNA2021-04-162021-04-1647.162230MrsVidya Rajiv Yeravdekar02183179Non-Executive - Independent DirectorNot Applicable1964-06-28falseActiveNA2021-04-162021-04-1647.162220MrShailesh Kripalu AyyangarAEIPA8567L00268076Non-Executive - Independent DirectorNot Applicable1954-10-15falseActiveNA2023-06-022023-06-0221.32231truetruetruetruetrueAudit Committee01173236Palamadai Sundararajan JayakumarNon-Executive - Independent DirectorChairperson2020-07-22Audit Committee00153675Berjis Minoo DesaiNon-Executive - Non Independent DirectorMember2005-06-17Audit Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-27Nomination and remuneration committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorChairperson2022-07-27Nomination and remuneration committee01173236Palamadai Sundararajan JayakumarNon-Executive - Independent DirectorMember2021-04-16Nomination and remuneration committee00153675Berjis Minoo DesaiNon-Executive - Non Independent DirectorMember2024-12-31Stakeholders Relationship Committee00153675Berjis Minoo DesaiNon-Executive - Non Independent DirectorChairperson2011-05-07Stakeholders Relationship Committee00118691Satish Ramanlal MehtaExecutive DirectorMember2011-05-07Stakeholders Relationship Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-27Risk Management Committee00268076Shailesh Kripalu AyyangarNon-Executive - Independent DirectorChairperson2023-06-02Risk Management Committee01173236Palamadai Sundararajan JayakumarNon-Executive - Independent DirectorMember2021-07-27Risk Management Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-27Risk Management Committee00153675Berjis Minoo DesaiNon-Executive - Non Independent DirectorMember2021-07-27Corporate Social Responsibility Committee00118469Sunil Rajanikant MehtaExecutive DirectorChairperson2013-11-26Corporate Social Responsibility Committee05318899Namita Vikas ThaparExecutive DirectorMember2014-10-20Corporate Social Responsibility Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-272024-11-07true111142025-02-0690true1093Risk Management Committee2024-12-19true4220Nomination and remuneration committee2024-11-07true3320Nomination and remuneration committee2025-02-0690true3320Audit Committee2024-11-07true3320Audit Committee2025-02-0690true3320Stakeholders Relationship Committee2024-11-07true3310Stakeholders Relationship Committee2025-02-0690true3310Corporate Social Responsibility Committee2025-02-06true3310truetruetruetrueYestruetruetrueChetan Rajendra SharmaCompany Secretary and Compliance OfficerYeshttps://www.emcure.com/wp-content/uploads/2025/04/Details-of-Business.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/02/EPL-COI-MOA-AOA.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/04/Brief-Profile-of-Board-of-Directors.pdfYeshttps://emcure.com/wp-content/themes/emcure/assets/images/Financials/Terms-and-conditions-of-appointment-of-independent-directors.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/01/Composition-of-Committees.pdfYeshttps://www.emcure.com/wp-content/uploads/2023/12/Code-Of-Conduct-for-Directors-and-Senior-Management_adopted-15.12.2023.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/01/EPL_Vigil-Mechanism-Policy.pdfYeshttps://www.emcure.com/wp-content/uploads/2024/01/Nomination-and-Remuneration-Policy_last-amended-11.12.2023.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/02/Related-Party-Transactions-Policy_Amendment-06.02.2025F.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/02/Policy-for-Determining-Material-Subsidiaries_Amendment_06.02.2025F.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/02/Details-of-Familiarization-Programme-imparted-to-Independent-Directors.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/04/Investor-Enquiry.pdfYeshttps://www.emcure.com/wp-content/uploads/2025/04/Investor-Enquiry.pdfYeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/Yeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/NAYeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/Yeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/NAYeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/Yeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/NANAYeshttps://www.emcure.com/wp-content/uploads/2024/01/Policy-for-Determining-Materiality-of-Events-and-Information-for-Disclosures_adopted-15.12.2023.pdfYeshttps://www.emcure.com/wp-content/uploads/2024/07/EPL-Intimation-of-contact-details-of-KMPs-for-determining-materiality-Reg-305.pdfYeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/Yeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/Yeshttps://www.emcure.com/wp-content/uploads/2023/12/Dividend-Distribution-Policy_adopted-15.12.2023.pdfYeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/Yeshttps://www.emcure.com/wp-content/uploads/2025/02/Emcure-Employee-Stock-Option-Scheme-2013.pdfYeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/Yeshttps://www.emcure.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/YesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNAYesNAYesNAYesNAYesYesYesYesNAYesYesYesNANAChetan Rajendra SharmaCompany Secretary and Compliance OfficerYesChetan Rajendra SharmaCompany Secretary and Compliance OfficerfalseChetan Rajendra SharmaCompany Secretary and Compliance OfficerPune2025-04-2900000Deputy Commissioner of Income tax, Central Circle 2 (1)- Pune2023-12-27The Company has received assessment orders u/s 143(3) rws 144C(3) and r.w.s 153A of the Income Tax Act, 1961, for the Financial Year 2014-15 until Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22) for an aggregate demand of Rs. 1,621.04 million payable on account of disallowance of certain advertisement and promotional expenses and transfer pricing adjustments made. The Company has filed appeals in relation to such orders with the Commissioner of Income Tax (Appeals).The cases are pending for disposal with Commissioner of Income Tax (Appeals).The cases are pending for disposal with Commissioner of Income Tax (Appeals).Deputy Commissioner of Income tax, Central Circle 2 (1)- Pune2022-10-22Subsidiary of Company, Zuventus Healthcare Limited (Zuventus) has received assessment orders u/s 143(3) r.w.s 144C(3) and r.w.s 153A of the Income Tax Act, 1961, for the Financial Year 2014-15 until Financial Year 2021-22 Assessment Year 2015-16 to Assessment Year 2022-23) for an aggregate demand of Rs. 814.79 million payable on account of disallowances of certain advertisement and promotional expenses. Zuventus has filed appeals in relation to such orders with the Commissioner of Income Tax (Appeals). The cases are pending for disposal with Commissioner of Income Tax (Appeals).The cases are pending for disposal with Commissioner of Income Tax (Appeals).